Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mai, J. C.
Right arrow Articles by Robbins, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mai, J. C.
Right arrow Articles by Robbins, P. D.
[Cancer Research 61, 7709-7712, November 1, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

A Proapoptotic Peptide for the Treatment of Solid Tumors1

Jeffrey C. Mai, Zhibao Mi, Seon-Hee Kim, Bobby Ng and Paul D. Robbins2

Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261

We have designed a novel peptide, DP1, which is able to mediate significant induction of apoptosis in solid tumors by local injection. This peptide, comprised of a protein transduction domain (PTD), PTD-5, fused to an antimicrobial peptide, (KLAKLAK)2, was able to trigger rapid apoptosis in a variety of cell lines in vitro, including MCA205 murine fibrosarcomas and human head and neck tumors. Furthermore, direct injection of DP1 into day 7 established MCA205 tumors in C57BL/6 mice resulted in the induction of tumor apoptosis and subsequent reduction in tumor volume. These results suggest that DP1 may be used clinically to treat accessible solid tumors or as an adjuvant therapy in conjunction with radiotherapy, standard chemotherapy, immunotherapy, or surgical debulking.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
E. Kondo, T. Tanaka, T. Miyake, T. Ichikawa, M. Hirai, M. Adachi, K. Yoshikawa, K. Ichimura, N. Ohara, A. Moriwaki, et al.
Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines
Mol. Cancer Ther., June 1, 2008; 7(6): 1461 - 1471.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. H. Dave, J. S. Tilstra, K. Matsuoka, F. Li, T. Karrasch, J. K. Uno, A. R. Sepulveda, C. Jobin, A. S. Baldwin, P. D. Robbins, et al.
Amelioration of Chronic Murine Colitis by Peptide-Mediated Transduction of the I{kappa}B Kinase Inhibitor NEMO Binding Domain Peptide
J. Immunol., December 1, 2007; 179(11): 7852 - 7859.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J.-K. Ko, K.-H. Choi, Z. Pan, P. Lin, N. Weisleder, C.-W. Kim, and J. Ma
The tail-anchoring domain of Bfl1 and HCCS1 targets mitochondrial membrane permeability to induce apoptosis
J. Cell Sci., August 15, 2007; 120(16): 2912 - 2923.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Rege, S. J. Patel, Z. Megeed, and M. L. Yarmush
Amphipathic Peptide-Based Fusion Peptides and Immunoconjugates for the Targeted Ablation of Prostate Cancer Cells
Cancer Res., July 1, 2007; 67(13): 6368 - 6375.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Rotem, I. Radzishevsky, and A. Mor
Physicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives.
Antimicrob. Agents Chemother., August 1, 2006; 50(8): 2666 - 2672.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
B. Law, L. Quinti, Y. Choi, R. Weissleder, and C.-H. Tung
A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity.
Mol. Cancer Ther., August 1, 2006; 5(8): 1944 - 1949.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Papo, A. Braunstein, Z. Eshhar, and Y. Shai
Suppression of Human Prostate Tumor Growth in Mice by a Cytolytic D-, L-Amino Acid Peptide: Membrane Lysis, Increased Necrosis, and Inhibition of Prostate-Specific Antigen Secretion
Cancer Res., August 15, 2004; 64(16): 5779 - 5786.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Takada, S. Singh, and B. B. Aggarwal
Identification of a p65 Peptide That Selectively Inhibits NF-{kappa} B Activation Induced by Various Inflammatory Stimuli and Its Role in Down-regulation of NF-{kappa}B-mediated Gene Expression and Up-regulation of Apoptosis
J. Biol. Chem., April 9, 2004; 279(15): 15096 - 15104.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. Nagel-Wolfrum, C. Buerger, I. Wittig, K. Butz, F. Hoppe-Seyler, and B. Groner
The Interaction of Specific Peptide Aptamers With the DNA Binding Domain and the Dimerization Domain of the Transcription Factor Stat3 Inhibits Transactivation and Induces Apoptosis in Tumor Cells
Mol. Cancer Res., March 1, 2004; 2(3): 170 - 182.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. J. Zurita, P. Troncoso, M. Cardo-Vila, C. J. Logothetis, R. Pasqualini, and W. Arap
Combinatorial Screenings in Patients: The Interleukin-11 Receptor {alpha} as a Candidate Target in the Progression of Human Prostate Cancer
Cancer Res., January 15, 2004; 64(2): 435 - 439.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. C. Mai, H. Shen, S. C. Watkins, T. Cheng, and P. D. Robbins
Efficiency of Protein Transduction Is Cell Type-dependent and Is Enhanced by Dextran Sulfate
J. Biol. Chem., August 9, 2002; 277(33): 30208 - 30218.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.